drugset / Trial / NCT01200784
Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
RandomizedParallel-groupDouble-blindTreatment
Summary
Study hypothesis: Nicotinamide inhibits gastrointestinal phosphate absorption and serum phosphate levels of dialysis patients in a dose dependent manner.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-06
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotinamide | Other / unclassified | 250 mg | — |
| Subject | Nicotinamide | Other / unclassified | 500 mg | — |
| Subject | Nicotinamide | Other / unclassified | 750 mg | — |
| Subject | Nicotinamide | Other / unclassified | 1000 mg | — |